Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Peetermans, Marijke ^a   Vanassche, Thomas ^a   Liesenborghs, Laurens ^a   Claes, Jorien ^a   Velde, Greetje Vande ^b   Kwiecinksi, Jakub ^c   Jin, Tao ^c   De Geest, Bart ^a   Hoylaerts, Marc F ^a   Lijnen, Roger H ^a   Verhamme, Peter ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b KU Leuven   (Belgium)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Fibrinolysis; Matrix metalloproteinases; Plasminogen; Skin infection; Staphylococcus aureus; Staphylokinase

Indexed keywords

ADENOVIRUS VECTOR; ALPHA 2 ANTIPLASMIN; FIBRIN; GELATINASE; GELATINASE A; GELATINASE B; PLASMIN; PLASMINOGEN; STAPHYLOKINASE; AUR PROTEIN, STAPHYLOCOCCUS AUREUS; METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BIOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBRINOLYSIS; GENE EXPRESSION; HOST PATHOGEN INTERACTION; IN VITRO STUDY; IN VIVO STUDY; MICROBIAL ACTIVITY; MOUSE; NONHUMAN; PHENOTYPE; PLASMINOGEN ACTIVATION; PROTEIN DEGRADATION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; ANIMAL; C57BL MOUSE; DISEASE MODEL; ENZYMOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SKIN; TRANSGENIC MOUSE;

BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; DISEASE MODELS, ANIMAL; FIBRINOLYSIN; HOST-PATHOGEN INTERACTIONS; METALLOENDOPEPTIDASES; MICE, INBRED C57BL; MICE, TRANSGENIC; PLASMINOGEN; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84929300857     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-014-0310-7     Document Type: Article

References (48)

1. Ray GT, Suaya JA, Baxter R: Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 2013, 76:24-30.
2. Sader HS, Farrell DJ, Jones RN: Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres. Int J Antimicrob Agents 2010, 36:28-32.
3. Vanassche T, Verhaegen J, Peetermans WE, Van Ryn J, Cheng A, Schneewind O, Hoylaerts MF, Verhamme P: Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence. J Thromb Haemost 2011, 9:2436-2446.
4. Vanassche T, Peetermans M, Van Aelst L, Peetermans WE, Verhaegen J, Missiakas D, Schneewind O, Hoylaerts M, Verhamme P: The role of staphylothrombin-mediated fibrin deposition in catheter-related Staphylococcus aureus infections. J Infect Dis 2013, 208:92-100.
5. McAdow M, Kim HK, Dedent AC, Hendrickx AP, Schneewind O, Missiakas DM: Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog 2011, 7:e1002307.
6. Sawai T, Tomono K, Yanagihara K, Yamamoto Y, Kaku M, Hirakata Y, Koga H, Tashiro T, Kohno S: Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun 1997, 65:466-471.
7. Collen D: Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent. Nat Med 1998, 4:279-284.
8. Lijnen HR, Van Hoef B, De Cock F, Okada K, Ueshima S, Matsuo O, Collen D: On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J Biol Chem 1991, 266:11826-11832.
9. Kwiecinski J, Josefsson E, Mitchell J, Higgins J, Magnusson M, Foster T, Jin T, Bokarewa M: Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection. J Infect Dis 2010, 202:1041-1049.
10. Kwiecinski J, Jacobsson G, Karlsson M, Zhu X, Wang W, Bremell T, Josefsson E, Jin T: Staphylokinase Promotes the Establishment of Staphylococcus aureus Skin Infections While Decreasing Disease Severity. J Infect Dis 2013, 208: 990-9.
11. Lijnen HR, Stassen JM, Vanlinthout I, Fukao H, Okada K, Matsuo O, Collen D: Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis. Thromb Haemost 1991, 66:468-473.
12. Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY, Rozek LS, Wang X, Sjobring U, Ginsburg D: Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004, 305:1283-1286.
13. Khil J, Im M, Heath A, Ringdahl U, Mundada L, Cary Engleberg N, Fay WP: Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinase-independent mechanisms. J Infect Dis 2003, 188: 497-505.
14. Cook SM, Skora A, Walker MJ, Sanderson-Smith ML, McArthur JD: Site-restricted plasminogen activation mediated by group A streptococcal streptokinase variants. Biochem J 2014, 458:23-31.
15. Piechowicz L, Galin'ski J, Garbacz K, Haras K: Bacteriophage analysis of staphylokinase-negative Staphylococcus aureus strains isolated from people. J Basic Microbiol 2010, 50:557-561.
16. Jin T, Bokarewa M, McIntyre L, Tarkowski A, Corey GR, Reller LB, Fowler VG Jr: Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol 2003, 52:919-923.
17. Ruotsalainen E, Karden-Lilja M, Kuusela P, Vuopio-Varkila J, Virolainen-Julkunen A, Sarna S, Valtonen V, Jarvinen A: Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics. J Infect 2008, 56:249-256.
18. Luedicke C, Slickers P, Ehricht R, Monecke S: Molecular fingerprinting of Staphylococcus aureus from bone and joint infections. Eur J Clin Microbiol Infect Dis 2010, 29:457-463.
19. Monecke S, Luedicke C, Slickers P, Ehricht R: Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur J Clin Microbiol Infect Dis 2009, 28:1159-1165.
20. Monecke S, Berger-Bachi B, Coombs G, Holmes A, Kay I, Kearns A, Linde HJ, O'Brien F, Slickers P, Ehricht R: Comparative genomics and DNA array-based genotyping of pandemic Staphylococcus aureus strains encoding Panton-Valentine leukocidin. Clin Microbiol Infect 2007, 13: 236-249.
21. van Wamel WJ, Rooijakkers SH, Ruyken M, van Kessel KP, van Strijp JA: The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol 2006, 188:1310-1315.
22. Humphreys H, Keane CT, Hone R, Pomeroy H, Russell RJ, Arbuthnott JP, Coleman DC: Enterotoxin production by Staphylococcus aureus isolates from cases of septicaemia and from healthy carriers. J Med Microbiol 1989, 28:163-172.
23. Katayama Y, Baba T, Sekine M, Fukuda M, Hiramatsu K: Beta-hemolysin promotes skin colonization by Staphylococcus aureus. J Bacteriol 2013, 195:1194-1203.
24. Resch G, Francois P, Morisset D, Stojanov M, Bonetti EJ, Schrenzel J, Sakwinska O, Moreillon P: Human-to-bovine jump of Staphylococcus aureus CC8 is associated with the loss of a beta-hemolysin converting prophage and the acquisition of a new staphylococcal cassette chromosome. PLoS ONE 2013, 8:e58187.
25. Gladysheva IP, Turner RB, Sazonova IY, Liu L, Reed GL: Coevolutionary patterns in plasminogen activation. Proc Natl Acad Sci U S A 2003, 100:9168-9172.
26. Kim SH, Chun HS, Han MH, Park NY, Suk K: A novel variant of staphylokinase gene from Staphylococcus aureus ATCC 29213. Thromb Res 1997, 87:387-395.
27. Sako T, Sawaki S, Sakurai T, Ito S, Yoshizawa Y, Kondo I: Cloning and expression of the staphylokinase gene of Staphylococcus aureus in Escherichia coli. Mol Gen Genet 1983, 190:271-277.
28. Behnke D, Gerlach D: Cloning and expression in Escherichia coli, Bacillus subtilis, and Streptococcus sanguis of a gene for staphylokinase-a bacterial plasminogen activator. Mol Gen Genet 1987, 210:528-534.
29. Coleman DC, Sullivan DJ, Russell RJ, Arbuthnott JP, Carey BF, Pomeroy HM: Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: molecular mechanism of triple conversion. J Gen Microbiol 1989, 135:1679-1697.
30. Sumby P, Waldor MK: Transcription of the toxin genes present within the Staphylococcal phage phiSa3ms is intimately linked with the phage's life cycle. J Bacteriol 2003, 185:6841-6851.
31. Lijnen HR: Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001, 86:324-333.
32. Collen D: Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur J Biochem 1976, 69:209-216.
33. Molkanen T, Tyynela J, Helin J, Kalkkinen N, Kuusela P: Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase. FEBS Lett 2002, 517:72-78.
34. Furuya H, Ikeda R: Interaction of triosephosphate isomerase from Staphylococcus aureus with plasminogen. Microbiol Immunol 2011, 55:855-862.
35. Koch TK, Reuter M, Barthel D, Bohm S, van den Elsen J, Kraiczy P, Zipfel PF, Skerka C: Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b. PLoS ONE 2012, 7: e47638.
36. Souza NM, Vieira ML, Alves IJ, de Morais ZM, Vasconcellos SA, Nascimento AL: Lsa30, a novel adhesin of Leptospira interrogans binds human plasminogen and the complement regulator C4bp. Microb Pathog 2012, 53:125-134.
37. Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A: Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 2004, 172:1169-1176.
38. Rooijakkers SH, van Wamel WJ, Ruyken M, van Kessel KP, van Strijp JA: Anti-opsonic properties of staphylokinase. Microbes Infect 2005, 7: 476-484.
39. Foster TJ, Hook M: Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 2003, 48:1429-49.
40. Novick RP: Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 2003, 48:1429-1449.
41. Lijnen HR: Gene targeting in hemostasis. Alpha2-antiplasmin. Front Biosci 2001, 6:D239-247.
42. Feng Y, Jacobs F, Van Craeyveld E, Lievens J, Snoeys J, Van Linthout S, De Geest B: The impact of antigen expression in antigen-presenting cells on humoral immune responses against the transgene product. Gene Ther 2010, 17:288-293.
43. Van Linthout S, Lusky M, Collen D, De Geest B: Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector. Gene Ther 2002, 9:1520-1528.
44. Deutsch DG, Mertz ET: Plasminogen: purification from human plasma by affinity chromatography. Science 1970, 170:1095-1096.
45. Verhamme P, Goossens G, Maleux G, Collen D, Stas M: A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion. J Thromb Thrombolysis 2007, 24:1-5.
46. Holvoet P, Lijnen HR, Collen D: A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusion. Blood 1986, 67:1482-1487.
47. Van Hul M, Lijnen HR: Effect of weight loss on gelatinase levels in obese mice. Clin Exp Pharmacol Physiol 2011, 38:647-649.
48. Van Hul M, Lijnen HR: A functional role of gelatinase A in the development of nutritionally induced obesity in mice. J Thromb Haemost 2008, 6:1198-1206.